Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational study

26 Dec 2022

Abstract excerpt

OBJECTIVE: To define the residual risk of morbidity-related outcome in fetuses with nuchal translucency (NT) of 3.5 mm or more after normal genetic testing and mid-trimester anomaly scan. METHODS: A total of 114 fetuses with isolated NT of 3.5 mm or more, normal karyotype, and array-based comparative genomic hybridization (array-CGH) were included and divided in three groups: NT 3.5-4.5 mm, NT 4.5-6 mm, and NT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36572018
DOI: 10.1002/ijgo.14637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational studyPMID 36572018Read ↗

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimesterSemantic proximity Read ↗

Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mmSemantic proximity Read ↗

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature reviewSemantic proximity Read ↗

Microarray and RASopathy‐disorder testing in fetuses with increased nuchal translucencySemantic proximity Read ↗

Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Application of chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

Increased nuchal translucency with normal karyotype and anomaly scan: What next?Semantic proximity Read ↗

Outcome of fetuses with enlarged nuchal translucency and normal karyotypeSemantic proximity Read ↗

Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.